environmental burden of disease | EBD

burden of disease | disease burden

global burden of disease | GBD [Abbr.]

disease prevalence | illness prevalence

perceived morbidity [ subjective morbidity ]

disease patterns

perceived morbidity | subjective morbidity

morbidity | diseased state

Global health situation: mortality, morbidity and disability, selected diseases, all ages, 1996 estimates

BURDEN — Burden of Resistance and Disease in European Nations (2007-2010) is a project which aims to provide comparable information on the burden of disease and resistance across Europe and to generate awareness and understanding among policy-makers and communities at large.

Environmental, occupational, life-style and socio-economic factors are relevant in several of these conditions with up to one third of the global disease burden estimated to be related to these.

Environmental, occupational, life-style and socio-economic factors are relevant in several of these conditions with up to one third of the global disease burden estimated to be related to these.

In 2012, the project RARECARENET (Information Network on Rare Cancers)[46], which built upon some of previous activities of the Project RARECARE (Surveillance of Rare Cancers in Europe)[47] which provided estimations for incidence, survival, prevalence and mortality for all rare cancers. The project aims (i) to provide updated indicators of rare cancer burden, (ii) to collect and disseminate information on the health care pathways for rare cancers, (iii) to identify the criteria for centres of expertise for rare cancers, (iv) to produce and disseminate information on diagnosis and management of rare cancers, (v) to develop a clinical dat ...[+++]abase on very rare cancers, (vi) to provide new knowledge on these diseases and their clinical management, and (vii) to develop and disseminate information for patients including a list of patients’ associations dedicated to rare cancers. In 2013, the European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment (ExPO-r-NeT), to support the provision of healthcare to children and young people with cancer in a Member State other than the Member State of affiliation, when the expertise with certain cancer conditions is rare and case volume low, contributing to provide cross-border best care to rare childhood cancer populations.